NASDAQ | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| MRNA | Moderna Inc | Healthcare | Biotechnology | 3.38% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.2% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 3.03% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 2.97% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 2.7% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.48% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.39% |
| BIO | Bio-Rad Laboratories Inc | Healthcare | Medical Devices | 2.38% |
| CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.26% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 2.08% |
| MAAC | Montes Archimedes Acquisition Corp | Financial Services | Shell Companies | 2% |
| VKTX | Viking Therapeutics Inc | Healthcare | Biotechnology | 1.82% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 1.73% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 1.6% |
| INSP | Inspire Medical Systems Inc | Healthcare | Medical Devices | 1.59% |
| CYTK | Cytokinetics Inc | Healthcare | Biotechnology | 1.52% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 1.48% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 1.47% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.37% |
| APLS | Apellis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.35% |
Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies in the healthcare sector. It invests significantly in early-stage companies within the healthcare equipment and supplies, pharmaceuticals, biotechnology, and life sciences industries that are not yet consistently profitable.